These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15560567

  • 1. Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene.
    Clewell HJ, Andersen ME.
    Crit Rev Toxicol; 2004; 34(5):385-445. PubMed ID: 15560567
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT, Gold LS.
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [Abstract] [Full Text] [Related]

  • 4. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene.
    Clewell HJ, Gentry PR, Gearhart JM, Allen BC, Andersen ME.
    Chemosphere; 1995 Jul; 31(1):2561-78. PubMed ID: 7670867
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
    Fisher JW, Allen BC.
    Risk Anal; 1993 Feb; 13(1):87-95. PubMed ID: 8451463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.
    Caldwell JC, Keshava N.
    Environ Health Perspect; 2006 Sep; 114(9):1457-63. PubMed ID: 16966105
    [Abstract] [Full Text] [Related]

  • 11. Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.
    Moore MM, Harrington-Brock K.
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):215-23. PubMed ID: 10807553
    [Abstract] [Full Text] [Related]

  • 12. Trichloroethylene cancer epidemiology: a consideration of select issues.
    Scott CS, Chiu WA.
    Environ Health Perspect; 2006 Sep; 114(9):1471-8. PubMed ID: 16966107
    [Abstract] [Full Text] [Related]

  • 13. Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.
    Rhomberg LR.
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):343-58. PubMed ID: 10807564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Issues in the pharmacokinetics of trichloroethylene and its metabolites.
    Chiu WA, Okino MS, Lipscomb JC, Evans MV.
    Environ Health Perspect; 2006 Sep; 114(9):1450-6. PubMed ID: 16966104
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.